-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Outset Medical (NASDAQ:OM) & Vivani Medical (NASDAQ:VANI) Head-To-Head Comparison
Outset Medical (NASDAQ:OM) & Vivani Medical (NASDAQ:VANI) Head-To-Head Comparison
Outset Medical (NASDAQ:OM – Get Rating) and Vivani Medical (NASDAQ:VANI – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, analyst recommendations and dividends.
Profitability
This table compares Outset Medical and Vivani Medical's net margins, return on equity and return on assets.
Get Outset Medical alerts:| Net Margins | Return on Equity | Return on Assets | |
| Outset Medical | -145.93% | -49.75% | -39.16% |
| Vivani Medical | N/A | -8.27% | -7.86% |
Analyst Ratings
This is a summary of current ratings for Outset Medical and Vivani Medical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Outset Medical | 0 | 1 | 4 | 0 | 2.80 |
| Vivani Medical | 0 | 0 | 1 | 0 | 3.00 |
Institutional & Insider Ownership
98.8% of Outset Medical shares are owned by institutional investors. 4.0% of Outset Medical shares are owned by insiders. Comparatively, 47.2% of Vivani Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Valuation and Earnings
This table compares Outset Medical and Vivani Medical's revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Outset Medical | $102.60 million | 12.74 | -$131.93 million | ($3.42) | -7.91 |
| Vivani Medical | N/A | N/A | -$8.92 million | N/A | N/A |
Vivani Medical has lower revenue, but higher earnings than Outset Medical.
Risk & Volatility
Outset Medical has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.54, suggesting that its stock price is 154% more volatile than the S&P 500.
Summary
Vivani Medical beats Outset Medical on 8 of the 11 factors compared between the two stocks.
About Outset Medical
(Get Rating)
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
About Vivani Medical
(Get Rating)
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Receive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.com's FREE daily email newsletter.
Outset Medical (NASDAQ:OM – Get Rating) and Vivani Medical (NASDAQ:VANI – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, analyst recommendations and dividends.
Inconsent Medical（纳斯达克股票代码：OM — 获取评级）和Vivani Medical（纳斯达克股票代码：VANI — Get Rating）都是小型医疗公司，但哪项投资更好？我们将根据两家公司的估值、收益、盈利能力、风险、机构所有权、分析师建议和股息对比这两家公司。
Profitability
盈利能力
This table compares Outset Medical and Vivani Medical's net margins, return on equity and return on assets.
该表比较了Inconsourt Medical和Vivani Medical的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Outset Medical | -145.93% | -49.75% | -39.16% |
| Vivani Medical | N/A | -8.27% | -7.86% |
| 净利润 | 股本回报率 | 资产回报率 | |
| 初出医疗 | -145.93% | -49.75% | -39.16% |
| 维瓦尼医疗 | 不适用 | -8.27% | -7.86% |
Analyst Ratings
分析师评级
This is a summary of current ratings for Outset Medical and Vivani Medical, as provided by MarketBeat.com.
这是Marketbeat.com提供的Inconsurt Medical和Vivani Medical当前评级摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Outset Medical | 0 | 1 | 4 | 0 | 2.80 |
| Vivani Medical | 0 | 0 | 1 | 0 | 3.00 |
| 卖出评级 | 保持收视率 | 买入评级 | 强劲的买入评级 | 评分分数 | |
| 初出医疗 | 0 | 1 | 4 | 0 | 2.80 |
| 维瓦尼医疗 | 0 | 0 | 1 | 0 | 3.00 |
Institutional & Insider Ownership
机构所有权和内部所有权
98.8% of Outset Medical shares are owned by institutional investors. 4.0% of Outset Medical shares are owned by insiders. Comparatively, 47.2% of Vivani Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
98.8％的Encorment Medical股票由机构投资者持有。4.0％的Encorment Medical股票由内部人士持有。相比之下，47.2％的Vivani Medical股份由内部人士持有。强大的机构所有权表明，捐赠基金、大型基金经理和对冲基金认为，从长远来看，股票的表现将超过市场。
Valuation and Earnings
估值和收益
This table compares Outset Medical and Vivani Medical's revenue, earnings per share (EPS) and valuation.
该表比较了Encorment Medical和Vivani Medical的收入、每股收益（EPS）和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Outset Medical | $102.60 million | 12.74 | -$131.93 million | ($3.42) | -7.91 |
| Vivani Medical | N/A | N/A | -$8.92 million | N/A | N/A |
| 总收入 | 价格/销售比率 | 净收入 | 每股收益 | 市盈率 | |
| 初出医疗 | 1.0260 亿美元 | 12.74 | -1.3193 亿美元 | (3.42 美元) | -7.91 |
| 维瓦尼医疗 | 不适用 | 不适用 | -892 万美元 | 不适用 | 不适用 |
Vivani Medical has lower revenue, but higher earnings than Outset Medical.
Vivani Medical的收入较低，但收入却高于Encent Medical。
Risk & Volatility
风险与波动性
Outset Medical has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.54, suggesting that its stock price is 154% more volatile than the S&P 500.
Encorment Medical的beta值为1.49，这表明其股价的波动性比标准普尔500指数高49％。相比之下，Vivani Medical的beta值为2.54，这表明其股价的波动性比标准普尔500指数高154％。
Summary
摘要
Vivani Medical beats Outset Medical on 8 of the 11 factors compared between the two stocks.
与两只股票进行比较的11个因素中，Vivani Medical在8个因素上击败了Encroust Medica
About Outset Medical
关于《开创医疗》
(Get Rating)
（获取评分）
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
医疗技术公司Encorment Medical, Inc. 开发了一种用于透析的血液透析系统。它提供了 Tablo 血液透析系统，该系统包括一个紧凑的控制台，该控制台集成了水净化、按需生产透析液以及用于急性和家庭环境中的透析护理的软件和连接功能。该公司前身为 Home Dialysis Plus, Ltd.，并于 2015 年 1 月更名为 Encorting Medical, Inc.Encorting Medical, Inc. 成立于 2003 年，总部位于加利福尼亚州圣何塞。
About Vivani Medical
关于 Vivani Medical
(Get Rating)
（获取评分）
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Vivani Medical, Inc. 是一家临床阶段的公司，开发了各种植入物，用于治疗医疗需求未得到满足的慢性病。它致力于开发微型药物植入物产品组合，以提供最小的药物特征波动；以及用于为盲人提供有用的人工视觉的植入式视觉假体设备组合。该公司总部位于加利福尼亚州埃默里维尔。
Receive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.com's FREE daily email newsletter.
接收《创始医学日报》的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Inconsourt Medical及相关公司的最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Futu Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Futu Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Futu Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Futu Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧